In examining
these remaining myeloma cells, the Yale team discovered a previously unidentified biologic pathway induced by the immune modulating drugs that enabled the residual cancer cells to survive and proliferate.
Not exact matches
While the cause of MGUS and multiple
myeloma (plasma
cell cancer)
remains largely unclear, studies have reported an elevated risk of multiple
myeloma among farmers and other agricultural workers and pesticides have been thought to be the basis for these associations, according to study background.
A new study by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) provides evidence that genetically modifying immune
cells might effectively treat multiple
myeloma, a disease that
remains incurable and will account for an estimated 24,000 new cases and 11,100 deaths in 2014